Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DIRECTA PLUS PLC Remuneration Information 2019

May 28, 2019

7601_dirs_2019-05-28_fff69cd9-ccd2-4b43-af30-a23ab2c44c08.html

Remuneration Information

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2207A

Directa Plus PLC

28 May 2019

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE EU MARKET ABUSE REGULATION (596/2014). UPON THE PUBLICATION OF THE ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

28 May 2019

Directa Plus plc

("Directa Plus" or the "Company")

Director/PDMR Shareholdings - Amendments to Terms of Options

Directa Plus (AIM: DCTA), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets announces certain amendments to long-term options held by certain option holders of the Company.

At the time of its admission to AIM on 27 May 2016 the Company established a performance related employee share scheme and granted a total of 1,099,539 options ("Options") to purchase ordinary shares of 0.25p each in the Company to certain executive directors and senior employees of the Company ("Option holders"), subject to meeting of certain objective targets, namely growth in EBITDA, share price and production targets, in line with the Company's forecasts prior to Admission. These awards were to vest on the third anniversary of the date of grant, being 27 May 2019.

The production capacity target has been satisfied and, as a result 33.3% of each award vested on the 27 May 2019 and is exercisable on or after today 28 May 2019. The Remuneration Committee have considered the impact of extending or not extending the remaining 66.7% of the Options and it was concluded that it was in the best interests of all shareholders that the scheme been amended such that these outstanding Options may be exercised on or after 27 May 2020, subject to meeting a new objective target, namely growth in revenue

This announcement has been approved by Giulio Cesareo, Chief Executive, on behalf of the Company.

For further information please visit http://www.directa-plus.com/ or contact:

Directa Plus plc +39 02 36714458
Giulio Cesareo, CEO
Marco Ferrari, CFO
Cantor Fitzgerald Europe (Nominated Adviser and Joint Broker) +44 20 7894 7000
Rick Thompson, Philip Davies Will Goode (Corporate Finance)
Caspar Shand Kydd (Sales)
N+1 Singer (Joint Broker) +44 20 7496 3069
Mark Taylor, Lauren Kettle
Tavistock (Financial PR and IR) +44 20 7920 3150
Simon Hudson, Edward Lee, Barnaby Hayward

Notification and public disclosure of transactions by Persons Discharging Managerial Responsibilities ("PDMR") and persons closely associated with them ("PCA")

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014
1 Details of the person discharging managerial responsibilities/person closely associated
a. Name Giulio Cesareo
2 Reason for notification
a. Position/Status PDMR

Chief Executive Officer
b. Initial notification/

Amendment
Initial Notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a. Name
b. LEI N/A
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a. Description of the financial instrument, type of instrument



Identification Code
Options over Ordinary Shares of 0.25p each



 

ISIN: GB00BSM98843
b. Nature of the transaction Extension of option exercise period to 27 May 2020
c. Price(s) and volume(s) Price(s)

 n/a
Volume(s)

 363,469
d. Aggregated information

- Aggregated Volume

- Price
Volume: 363,469

Price: n/a
e. Date of the transaction 2019-05-27
f. Place of the transaction Outside of trading venue
Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014
1 Details of the person discharging managerial responsibilities/person closely associated
a. Name Marco Ferrari
2 Reason for notification
a. Position/Status PDMR

Chief Financial Officer
b. Initial notification/

Amendment
Initial Notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a. Name
b. LEI N/A
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a. Description of the financial instrument, type of instrument



Identification Code
Options over Ordinary Shares of 0.25p each



 

ISIN: GB00BSM98843
b. Nature of the transaction Extension of option exercise period to 27 May 2020
c. Price(s) and volume(s) Price(s)

 n/a
Volume(s)

176,970
d. Aggregated information

- Aggregated Volume

- Price
Volume: 176,970

Price:  n/a
e. Date of the transaction 2019-05-27
f. Place of the transaction Outside of trading venue
Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014
1 Details of the person discharging managerial responsibilities/person closely associated
a. Name Laura Rizzi
2 Reason for notification
a. Position/Status PDMR

Research & Development Manager
b. Initial notification/

Amendment
Initial Notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a. Name
b. LEI N/A
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a. Description of the financial instrument, type of instrument



Identification Code
Options over Ordinary Shares of 0.25p each



 

ISIN: GB00BSM98843
b. Nature of the transaction Extension of option exercise period to 27 May 2020
c. Price(s) and volume(s) Price(s)

 n/a
Volume(s)

 83,720
d. Aggregated information

- Aggregated Volume

- Price
Volume: 83,720

Price:  n/a
e. Date of the transaction 2019-05-27
f. Place of the transaction Outside of trading venue
Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014
1 Details of the person discharging managerial responsibilities/person closely associated
a. Name Razvan Popescu
2 Reason for notification
a. Position/Status PDMR

Chief Operating Officer
b. Initial notification/

Amendment
Initial Notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a. Name
b. LEI N/A
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a. Description of the financial instrument, type of instrument



Identification Code
Options over Ordinary Shares of 0.25p each



 

ISIN: GB00BSM98843
b. Nature of the transaction Extension of option exercise period to 27 May 2020
c. Price(s) and volume(s) Price(s)

 n/a
Volume(s)

 108,904
d. Aggregated information

- Aggregated Volume

- Price
Volume: 108,904

Price:  n/a
e. Date of the transaction 2019-05-27
f. Place of the transaction Outside of trading venue

About Directa Plus

Our focus is principally on the two sectors in which we have strong commercial advantage through developed and launched products and a technological lead: environmental (based on our Grafysorber® product) and textiles (based on our G+ products). In addition, we will continue to pursue opportunities in elastomers and composites (including tyres and asphalt), also using our G+ products.  All our products are hypoallergenic, non-toxic and sustainably produced.

-ends-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHCKODBOBKDOPB